STAAR Surgical Generates $464,000 in Cash from Operations During Thi...(uivalents ...),Health

Date:11/2/2009

uivalents 9 219 -- --- Decrease in cash and cash equivalents 652 (4,198) Cash and cash equivalents, at beginning of the period 4,992 10,895 ----- ------ Cash and cash equivalents, at end of the period $5,644 $6,697 ====== ====== STAAR Surgical Company GAAP Reconciliation Tables (in 000's) Unaudited Three Months Ended 10/2/2009 --------------------------------- Three Months As Effect of Ended Sales in Constant Currency Reported Currency Ex-Currency 9/26/2008 -------- --------- ----------- --------- US 4,017 - 4,017 4,746 International 14,096 54 14,042 13,366 ------ -- ------ ------ Total 18,113 54 18,059 18,112 ====== == ====== ====== Nine Months Ended 10/2/2009 --------------------------------- Nine Months As Effect of Ended Sales in Constant Currency Reported Currency Ex-Currency 9/26/2008
'/>"/>

SOURCE STAAR Surgical Company Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Related medicine technology :

1. STAAR Surgical to Present at the 20th Annual Oppenheimer Healthcare Conference in New York
2. STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call
3. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
4. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
5. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
6. New Non-Surgical Stem-Cell Procedure to Relieve Chronic Tendon Problems
7. Ceremeds OSTENE(R) Stops Bone Bleeding Without Added Risk of Surgical Infection, New Study Finds
8. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
9. Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
10. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
11. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery